Bayer HealthCare Pharmaceuticals is committed to the development of innovative pharmaceutical products that fulfill unmet medical needs. In the development of those products, clinical trials are conducted to determine their safety and efficacy. This clinical trial registry is intended to provide information about certain company-sponsored clinical trials in the U.S. It makes objective, scientific information about those trials publicly available in a standard summary format and helps increase the transparency of these Bayer HealthCare Pharmaceuticals clinical trials.

Bayer HealthCare Pharmaceuticals believes it has an ethical obligation to publish information about clinical trials. The company publishes information on these clinical trials in the scientific literature and participates in several local clinical trial protocol registries including the registry at www.clinicaltrials.gov. Details on clinical trials are provided to regulatory authorities, as required by law, prior to approval and marketing of all products.

This clinical trial information has been provided in accordance with the Joint Position on the Disclosure of Clinical Trial Information via Clinical Trial Registries and Databases, as endorsed by the following industry groups: European Federation of Pharmaceutical Industries and Associations (EFPIA), the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), the Japanese Pharmaceutical Manufacturers Association (JPMA) and the Pharmaceutical Research and Manufacturers of America (PhRMA).